Health & Fitness
Meet An “Amazing” Who Believes In The Value Of Curiosity
Tasuku Honjo, 78, Nobel Prize winner, helped develop an immunotherapeutic drug used in treating lung cancer and melanoma.

Tasuku Honjo, at 78, is an immunologist and physician/scientist Deputy Director-General and Distinguished Professor of Kyoto University Institute for Advanced Study. A few short years ago, he was awarded the Nobel Prize in Physiology or Medicine (2018), along with his colleague, James Allison, for the discovery of a protein that was significant in the development of an immunotherapeutic drug used in the treatment of lung cancer and melanoma.
Considering the critical importance immunotherapy is taking in much of contemporary scientific research, Tasuku’s discovery will no doubt continue to have far-reaching implications for cancer therapy. Tasuku believes that it is in following one’s curiosity and being willing to take on the challenge that advances scientific research. How fortunate we are that Tasuku followed his curiosity and was up to the challenge.
For more Amazings, go to https://www.Facebook.com/MeetTheAmazings.